NCT00166517View on ClinicalTrials.gov

V260 Registration Study (V260-013)(COMPLETED)

PHASE3CompletedINTERVENTIONAL
Enrollment

178

Participants

Timeline

Start Date

August 31, 2005

Primary Completion Date

July 31, 2006

Study Completion Date

July 31, 2006

Conditions
Rotavirus
Interventions
BIOLOGICAL

Rotavirus Vaccine, Live, Oral, Pentavalent

3 doses of rotavirus vaccine live, oral, pentavalent on Day 1, 28 to 70 days post Dose 1, and 28 to 70 days post Dose 2

BIOLOGICAL

Comparator: Placebo

3 doses of placebo to rotavirus vaccine live, oral, pentavalent on Day 1, 28 to 70 days post Dose 1, and 28 to 70 days post Dose 2

All Listed Sponsors
lead

Merck Sharp & Dohme LLC

INDUSTRY

NCT00166517 - V260 Registration Study (V260-013)(COMPLETED) | Biotech Hunter | Biotech Hunter